Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | SELL | P14151 | 2/20 | 0.46 |
| ▸ | SELP | P16109 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28507409 | 0.98 | CSNK2A1 (0.45) | CSNK2A1SELLSELPKDM4ETDP1 | |
| Hydrogen Sulfide SCHEMBL27850210 | 0.96 | CSNK2A1 (0.44) | CSNK2A1SELLSELPKDM4ETDP1 | |
| Propionic Acid SCHEMBL28409072 | 0.90 | HMGB1 (0.41) | CSNK2A1SELLSELPKDM4ETDP1 | |
| SCHEMBL2456581 | 0.86 | CSNK2A1 (0.47) | CSNK2A1SELLSELPKDM4ETDP1 | |
| Gallic Acid Methyl Ester SCHEMBL2573657 | 0.83 | LMNA (0.66) | SELLSELPKDM4ETDP1MEN1 | |
| SCHEMBL27534718 | 0.83 | LDHA (0.44) | CSNK2A1SELLSELPKDM4ETDP1 | |
| SCHEMBL3761832 | 0.82 | HMGB1 (0.52) | CSNK2A1KDM4ETDP1MEN1KMT2A | |
| SCHEMBL23756593 | 0.81 | CSNK2A1 (0.42) | CSNK2A1SELLSELPKDM4ETDP1 | |
| SCHEMBL23823369 | 0.78 | AKR1C2 (0.53) | KDM4ETDP1MEN1KMT2AALDH1A1 | |
| SCHEMBL3517151 | 0.78 | SELL (0.58) | SELLSELPKDM4ETDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1051 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4508118-B1 | DENDRITIC MOLECULES, PROCESS FOR THEIR PREPARATION AND USES THEREOF | SUPERBRANCHE (FR) | 2025-11-26 | — | — | EP | claimed |
| US-12240852-B2 | Co-crystals, method and apparatus for forming the same | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2025-03-04 | — | — | US | claimed |
| US-12187700-B2 | Polymorphs and cocrystals of a cardiac troponin activator | AMGEN INC. (US) | 2025-01-07 | — | — | US | claimed |
| EP-4255208-B1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2024-12-25 | — | — | EP | claimed |
| EP-3930472-B1 | COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2024-09-11 | — | — | EP | claimed |
| EP-3599633-B1 | POST ETCH RESIDUE CLEANING COMPOSITIONS AND METHODS OF USING THE SAME | VERSUM MAT US LLC (US) | 2023-12-06 | — | — | EP | claimed |
| US-11807873-B2 | Conversion of S-lignin compounds to useful intermediates | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2023-11-07 | — | — | US | claimed |
| US-20230144344-A1 | COMPOSITION FOR PREVENTING OR TREATING CARDIOVASCULAR AND METABOLIC DISEASES COMPRISING ELAEOCARPUS PETIOLATUS | SEOUL NATIONAL UNIVERSITY HOSPITAL (KR) | 2023-05-11 | — | — | US | claimed |
| US-11608324-B2 | Solid forms of fasoracetam | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2023-03-21 | — | — | US | claimed |
| US-11380537-B2 | Method of manufacturing a semiconductor device and a cleaning composition for an adhesive layer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-07-05 | — | — | US | claimed |
| EP-0832137-B1 | IMPREGNATED APPLICATOR TIP | CLOSURE MEDICAL CORP (US) | 2002-02-13 | — | — | EP | claimed |
| EP-1157693-A1 | USE OF EPIGALLOCATECHIN 3-O-(3-O-METHYL) GALLATE AND/OR EPIGALLOCATECHIN 3-O-(4-O-METHYL) GALLATE FOR THE TREATMENT OF ALLERGY AND/OR INFLAMMATION | National Agricultural Research Organisation (NARO) (JP) | 2001-11-28 | — | — | EP | claimed |
| EP-0840906-B1 | PROCESS FOR PRODUCING A PHOTOTHERMOGRAPHIC RECORDING MATERIAL | AGFA GEVAERT NV (BE) | 2001-10-24 | — | — | EP | claimed |
| EP-0619704-B1 | COMPOSITION FOR TREATING TUMORS HAVING HIGH TYROSINASE ACTIVITY | RUBIN DAVID (US) | 1999-03-31 | — | — | EP | claimed |
| EP-0649061-B1 | POSITIVE ELECTRON-BEAM RESIST COMPOSITION | TORAY INDUSTRIES (JP) | 1999-02-17 | — | — | EP | claimed |
| EP-0420893-B1 | REDUCIBLE INDICATORS CONTAINING PYROGALLOL AND USE THEREOF | BOEHRINGER MANNHEIM CORP (US) | 1995-07-26 | — | — | EP | claimed |
| EP-0501205-B1 | Antiphlogistic means | PLANTAMED ARZNEIMITTEL GMBH (DE) | 1995-05-24 | — | — | EP | claimed |
| EP-0501205-A1 | Antiphlogistic means | Plantamed Arzneimittel GmbH (DE) | 1992-09-02 | — | — | EP | claimed |
| EP-0044729-B1 | COBALT (III) COMPLEX-CONTAINING IMAGE-FORMING COMPOSITIONS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-09-26 | — | — | EP | claimed |
| US-4037004-A | Method for producing thermoplastic resin films or sheets for chelate color printing | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1977-07-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12187700-B2 | Polymorphs and cocrystals of a cardiac troponin activator | TNNT2, TNNI3, TNNC1 | CSNK2A1 339/4885SELL 2459/4885SELP 3117/4885 |
| US-11608324-B2 | Solid forms of fasoracetam | FAH, FASN, PFAS | CSNK2A1 4668/4885SELL 1432/4885SELP 2447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.